Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01459861 · ClinicalTrials.gov registry record · NA
Early Ambulation After Adductor Canal Block for Total Knee Arthroplasty
A NA study, sponsored by Trinity Health Of New England.
- Terminated
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT01459861 is a NA study that was terminated before completion, run by Trinity Health Of New England. The registered enrollment target is 11 participants.
The verdict
NCT01459861, a NA study, was terminated before completion, sponsored by Trinity Health Of New England.
- TERMINATED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
The purpose of this study is to assess early ambulation following total knee replacement in patients receiving continuous adductor canal block with posterior capsular injection compared to continuous femoral nerve block with tibial nerve block.
Interventions
- PROCEDURE Canal Block and Capsular Injection
- PROCEDURE Femoral Nerve Block with Tibial Nerve Block
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2011-10 |
| Est. Completion | 2012-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01459861
The ClinicalTrials.gov registry entry for NCT01459861 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Trinity Health Of New England, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Canal Block and Capsular Injection is the first listed.
NCT01459861 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01459861 about?
NCT01459861 is a clinical study titled "Early Ambulation After Adductor Canal Block for Total Knee Arthroplasty". The purpose of this study is to assess early ambulation following total knee replacement in patients receiving continuous adductor canal block with posterior capsular injection compared to continuous femoral nerve block with tibial nerve block.
What is the current status of trial NCT01459861?
This trial is currently terminated. It is a NA study. The enrollment target is 11 participants. The study started on 2011-10. Estimated completion is 2012-09.
What interventions are being tested in trial NCT01459861?
The interventions under investigation include: Canal Block and Capsular Injection (PROCEDURE), Femoral Nerve Block with Tibial Nerve Block (PROCEDURE).
Who is sponsoring clinical trial NCT01459861?
This trial is sponsored by Trinity Health Of New England, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.